208 related articles for article (PubMed ID: 26912295)
1. Cell Therapy for Parkinson's Disease.
Morizane A; Takahashi J
Neurol Med Chir (Tokyo); 2016; 56(3):102-9. PubMed ID: 26912295
[TBL] [Abstract][Full Text] [Related]
2. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
3. Stem Cells for Modeling and Therapy of Parkinson's Disease.
Zhang Q; Chen W; Tan S; Lin T
Hum Gene Ther; 2017 Jan; 28(1):85-98. PubMed ID: 27762639
[TBL] [Abstract][Full Text] [Related]
4. [Cell therapy for Parkinson's disease with induced pluripotent stem cells].
Morizane A
Rinsho Shinkeigaku; 2019 Mar; 59(3):119-124. PubMed ID: 30814448
[TBL] [Abstract][Full Text] [Related]
5. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
Staudt MD; Di Sebastiano AR; Xu H; Jog M; Schmid S; Foster P; Hebb MO
Gerontology; 2016; 62(3):371-80. PubMed ID: 26330171
[TBL] [Abstract][Full Text] [Related]
6. [Opportunities for neurorestorative therapies in PD using iPS and stem cells].
Ole I
Rinsho Shinkeigaku; 2010 Nov; 50(11):891. PubMed ID: 21921494
[No Abstract] [Full Text] [Related]
7. Cells therapy for Parkinson's disease--so close and so far away.
Ren Z; Zhang Y
Sci China C Life Sci; 2009 Jul; 52(7):610-4. PubMed ID: 19641865
[TBL] [Abstract][Full Text] [Related]
8. Regenerative medicine for Parkinson's disease.
Yasuhara T; Kameda M; Agari T; Date I
Neurol Med Chir (Tokyo); 2015; 55(2):113-23. PubMed ID: 25746305
[TBL] [Abstract][Full Text] [Related]
9. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
10. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
11. Autologous iPSC-derived dopamine neuron grafts show considerable promise in a nonhuman primate model of Parkinson's disease.
Wakeman DR
Mov Disord; 2015 Jul; 30(8):1034. PubMed ID: 26095814
[No Abstract] [Full Text] [Related]
12. [A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease].
Morizane A; Takahashi J
Brain Nerve; 2012 Jan; 64(1):29-37. PubMed ID: 22223499
[TBL] [Abstract][Full Text] [Related]
13. Cell-based therapies for Parkinson's disease.
Sakaguchi H; Takahashi J
Nihon Rinsho; 2017 Jan; 75(1):141-145. PubMed ID: 30566308
[TBL] [Abstract][Full Text] [Related]
14. [iPS cell therapy for Parkinson's disease].
Takahashi J
Rinsho Ketsueki; 2016 Aug; 57(8):1080-6. PubMed ID: 27599427
[TBL] [Abstract][Full Text] [Related]
15. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
[TBL] [Abstract][Full Text] [Related]
16. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.
Antonov SA; Novosadova EV
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806103
[TBL] [Abstract][Full Text] [Related]
17. The search for a curative cell therapy in Parkinson's disease.
Laguna Goya R; Tyers P; Barker RA
J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
[TBL] [Abstract][Full Text] [Related]
18. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
[TBL] [Abstract][Full Text] [Related]
19. A well-refined in vitro model derived from human embryonic stem cell for screening phytochemicals with midbrain dopaminergic differentiation-boosting potential for improving Parkinson's disease.
Hsieh WT; Chiang BH
J Agric Food Chem; 2014 Jul; 62(27):6326-36. PubMed ID: 24933592
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic differentiation using pluripotent stem cells.
Momčilović O; Montoya-Sack J; Zeng X
J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
